These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 283081

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of epsilon aminocaproic acid as an adjunct to replacement therapy in hemophiliacs undergoing tooth extraction (part II).
    Evans BE.
    N Y J Dent; 1981 Apr; 51(4):117-27. PubMed ID: 6784050
    [No Abstract] [Full Text] [Related]

  • 4. [Inhibitor hemophilia in oral surgery].
    Schulz S.
    Zahn Mund Kieferheilkd Zentralbl; 1984 Apr; 72(8):824-8. PubMed ID: 6240865
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U.
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
    Engelfriet CP, Reesink HW, Mannucci PM, Gringeri A, Ingerslev J, Brettler DB, Mauser-Bunschoten EP, Negrier C, Berntorp E, Smith OP, Shapiro AD.
    Vox Sang; 2000 Aug; 78(4):256-61. PubMed ID: 10970234
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
    Rup B.
    Dev Biol (Basel); 2003 Aug; 112():55-9. PubMed ID: 12762504
    [Abstract] [Full Text] [Related]

  • 11. [Circulating anticoagulants during hemophilia].
    Josso F, Cosson A, Gazengel C, Allain JP.
    Rev Fr Transfus; 1972 Dec; 15(4):281-98. PubMed ID: 4659598
    [No Abstract] [Full Text] [Related]

  • 12. Factor VIII inhibitors, natural history and management.
    Allain JP.
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):241-2. PubMed ID: 524148
    [No Abstract] [Full Text] [Related]

  • 13. Activated factor IX complex in treatment of surgical cases of hemophilia A with inhibitors.
    Hanna WT, Madigan RR, Miles MA, Lange RD.
    Thromb Haemost; 1981 Oct; 46(3):638-41. PubMed ID: 6976016
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE, Kerkhofs H, Leeksma CH.
    Schweiz Med Wochenschr; 1970 Oct 10; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response.
    Penner JA.
    Haemophilia; 2001 Jan 10; 7(1):103-8. PubMed ID: 11136390
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M.
    Rinsho Ketsueki; 1985 Jul 10; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.